Drug Approval | February 26, 2024
Concord Biotech receives GMP certificate from Kenya regulator
The said Unit complies with the prescribed Good Manufacturing practices as per relevant WHO technical Report Series
The said Unit complies with the prescribed Good Manufacturing practices as per relevant WHO technical Report Series
The acquisition enriches AstraZeneca’s growing pipeline of cell therapies with GC012F
The fast pace of construction of AIIMS Jammu whose foundation stone laying to inauguration took only 5 years highlights the commitment of the Government
VELSIPITY is the first and only oral advanced ulcerative colitis therapy approved for use in patients 16 years of age or older in the EU
Commercialization of rPEG lipids designed to improve immunogenicity profile for nucleic acid delivery
The Board has elected Dr. Ajit Shetty, who had served as the Company's Interim Chairperson of the Board since December 9, 2023, as Chairperson of the Board, effective February 13, 2024
The restructuring aims to create synergies across the business and strengthen capital structure
Through our research, we aim to ultimately provide new options for our customers to treat life-threatening infections in livestock
The talk show will be held monthly via Medanta's YouTube, Facebook and LinkedIn channe
Launches collaborative centre for translational research in head and neck cancer
Subscribe To Our Newsletter & Stay Updated
